Glycogen synthase kinase 3 negatively regulates IFN regulatory factor 3 transactivation through phosphorylation at its linker region

Innate Immunity

Volumn 20, Issue 1, 2014, Pages 78-87

  Wang, Jiin Tarng ^a   Chang, Ling Shih ^a   Chen, Chun Jen ^b   Doong, Shin Lian ^a   Chang, Chou Wei ^a   Chen, Mei Ru ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

EBV BGLF4 kinase; GSK3; IRF3; proline rich linker region

Indexed keywords

ASPARTIC ACID; BGLF 4 PROTEIN KINASE; GLUTAMIC ACID; GLUTATHIONE TRANSFERASE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; INTERFERON REGULATORY FACTOR 3; PROTEIN KINASE; SERINE; THREONINE; UNCLASSIFIED DRUG;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME REGULATION; EPSTEIN BARR VIRUS; IN VITRO STUDY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSACTIVATION; VIRUS INFECTION; WILD TYPE;

EBV BGLF4 KINASE; GSK3; IRF3; PROLINE-RICH LINKER REGION;

GLUTATHIONE TRANSFERASE; GLYCOGEN SYNTHASE KINASE 3; HEK293 CELLS; HERPESVIRUS 4, HUMAN; HUMANS; INTERFERON REGULATORY FACTOR-3; INTERFERON-GAMMA; MUTAGENESIS, INSERTIONAL; MUTATION; PHOSPHORYLATION; TRANSCRIPTIONAL ACTIVATION; VIRAL FUSION PROTEINS; VIRUS DISEASES;

EID: 84891342118     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425913485307     Document Type: Article

References (37)

1. Honda K, Takaoka A, Taniguchi T. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity. 2006 ; 25: 349-360
2. Saitoh T, Tun-Kyi A, Ryo A, et al. Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nat Immunol. 2006 ; 7: 598-605
3. Kim TK, Lee JS, Jung JE, et al. Interferon regulatory factor 3 activates p53-dependent cell growth inhibition. Cancer Lett. 2006 ; 242: 215-221
4. Kim TK, Lee JS, Oh SY, et al. Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells. Cancer Res. 2007 ; 67: 11133-11140
5. Hato SV, Ricour C, Schulte BM, et al. The mengovirus leader protein blocks interferon-alpha/beta gene transcription and inhibits activation of interferon regulatory factor 3. Cell Microbiol. 2007 ; 9: 2921-2930
6. Delhaye S, van Pesch V, Michiels T. The leader protein of Theiler's virus interferes with nucleocytoplasmic trafficking of cellular proteins. J Virol. 2004 ; 78: 4357-4362
7. Lefort S, Soucy-Faulkner A, Grandvaux N, Flamand L. Binding of Kaposi's sarcoma-associated herpesvirus K-bZIP to interferon-responsive factor 3 elements modulates antiviral gene expression. J Virol. 2007 ; 81: 10950-10960
8. Lin R, Genin P, Mamane Y, et al. HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators. Oncogene. 2001 ; 20: 800-811
9. Wang JT, Doong SL, Teng SC, et al. Epstein-Barr virus BGLF4 kinase suppresses the interferon regulatory factor 3 signaling pathway. J Virol. 2009 ; 83: 1856-1869
10. Hwang S, Kim KS, Flano E, et al. Conserved herpesviral kinase promotes viral persistence by inhibiting the IRF-3-mediated type I interferon response. Cell Host Microbe. 2009 ; 5: 166-178
11. Cole A, Frame S, Cohen P. Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event. Biochem J. 2004 ; 377: 249-255
12. Lochhead PA, Kinstrie R, Sibbet G, et al. A chaperone-dependent GSK3beta transitional intermediate mediates activation-loop autophosphorylation. Mol Cell. 2006 ; 24: 627-633
13. Frame S, Cohen P, Biondi RM. A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol Cell. 2001 ; 7: 1321-1327
14. Martin M, Rehani K, Jope RS, Michalek SM. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol. 2005 ; 6: 777-784
15. Wang H, Garcia CA, Rehani K, et al. IFN-beta production by TLR4-stimulated innate immune cells is negatively regulated by GSK3-beta. J Immunol. 2008 ; 181: 6797-6802
16. Lei CQ, Zhong B, Zhang Y, et al. Glycogen synthase kinase 3beta regulates IRF3 transcription factor-mediated antiviral response via activation of the kinase TBK1. Immunity. 2010 ; 33: 878-889
17. Chang TH, Liao CL, Lin YL. Flavivirus induces interferon-beta gene expression through a pathway involving RIG-I-dependent IRF-3 and PI3K-dependent NF-kappaB activation. Microbes Infect. 2006 ; 8: 157-171
18. Makarova O, Kamberov E, Margolis B. Generation of deletion and point mutations with one primer in a single cloning step. Biotechniques. 2000 ; 29: 970-972
19. Fitzgerald KA, McWhirter SM, Faia KL, et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol. 2003 ; 4: 491-496
20. Wang JT, Yang PW, Lee CP, et al. Detection of Epstein-Barr virus BGLF4 protein kinase in virus replication compartments and virus particles. J Gen Virol. 2005 ; 86: 3215-3225
21. Wu CH, Yeh SH, Tsay YG, et al. Glycogen synthase kinase-3 regulates the phosphorylation of severe acute respiratory syndrome coronavirus nucleocapsid protein and viral replication. J Biol Chem. 2009 ; 284: 5229-5239
22. Chen C, Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol. 1987 ; 7: 2745-2752
23. Chang LS, Wang JT, Doong SL, et al. Epstein-Barr virus BGLF4 kinase downregulates NF-kappaB transactivation through phosphorylation of coactivator UXT. J Virol. 2012 ; 86: 12176-12186
24. Chen MR, Chang SJ, Huang H, Chen JY. A protein kinase activity associated with Epstein-Barr virus BGLF4 phosphorylates the viral early antigen EA-D in vitro. J Virol. 2000 ; 74: 3093-3104
25. Obenauer JC, Cantley LC, Yaffe MB. Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res. 2003 ; 31: 3635-3641
26. Cohen P, Goedert M. GSK3 inhibitors: development and therapeutic potential. Nat Rev Drug Discov. 2004 ; 3: 479-487
27. Chesire DR, Dunn TA, Ewing CM, et al. Identification of aryl hydrocarbon receptor as a putative Wnt/beta-catenin pathway target gene in prostate cancer cells. Cancer Res. 2004 ; 64: 2523-2533
28. Dragan AI, Hargreaves VV, Makeyeva EN, Privalov PL. Mechanisms of activation of interferon regulator factor 3: the role of C-terminal domain phosphorylation in IRF-3 dimerization and DNA binding. Nucleic Acids Res. 2007 ; 35: 3525-3534
29. Shukla H, Vaitiekunas P, Majumdar AK, et al. The linker of the interferon response factor 3 transcription factor is not unfolded. Biochemistry. 2012 ; 51: 6320-6327
30. Woodgett JR, Ohashi PS. GSK3: an in-Toll-erant protein kinase?. Nat Immunol. 2005 ; 6: 751-752
31. Burch ML, Zheng W, Little PJ. Smad linker region phosphorylation in the regulation of extracellular matrix synthesis. Cell Mol Life Sci. 2011 ; 68: 97-107
32. Gao S, Alarcon C, Sapkota G, et al. Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling. Mol Cell. 2009 ; 36: 457-468
33. Millet C, Yamashita M, Heller M, et al. A negative feedback control of transforming growth factor-beta signaling by glycogen synthase kinase 3-mediated Smad3 linker phosphorylation at Ser-204. J Biol Chem. 2009 ; 284: 19808-19816
34. Alarcon C, Zaromytidou AI, Xi Q, et al. Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. Cell. 2009 ; 139: 757-769
35. Cohen-Solal KA, Merrigan KT, Chan JL, et al. Constitutive Smad linker phosphorylation in melanoma: a mechanism of resistance to transforming growth factor-beta-mediated growth inhibition. Pigment Cell Melanoma Res. 2011 ; 24: 512-524
36. Clement JF, Bibeau-Poirier A, Gravel SP, et al. Phosphorylation of IRF-3 on Ser 339 generates a hyperactive form of IRF-3 through regulation of dimerization and CBP association. J Virol. 2008 ; 82: 3984-3996
37. Panne D, McWhirter SM, Maniatis T, Harrison SC. Interferon regulatory factor 3 is regulated by a dual phosphorylation-dependent switch. J Biol Chem. 2007 ; 282: 22816-22822